The Asanté™ HIV-1 Rapid Recency® Assay is reliable, feasible, and acceptable for use at the point-of-care in Lusaka, Zambia
Data files
Apr 22, 2026 version files 15.22 KB
-
REACHZ_Dryad-20apr2026.csv
12.88 KB
-
README.md
2.35 KB
Abstract
Zambia established a recent infection testing algorithm (RITA) incorporating a novel point-of-care (POC) rapid test—the Asanté™ HIV-1 Rapid Recency® Assay (RTRI)—plus a viral load (VL) test to distinguish recent (≤12 months) from long-term (>12 months) HIV acquisition. This study evaluated the field performance of RTRI when implemented by healthcare workers at POC. We enrolled individuals newly diagnosed with HIV between 20 May 2021 and 10 March 2022 at the two Ministry of Health facilities in Lusaka, Zambia. Participants received on-site RTRI testing and provided an additional sample for repeat RTRI and VL testing at a central laboratory. Final recent infection testing algorithm (RITA) results were returned to the study sites and were made available to clients upon follow-up visit. Agreement between POC and laboratory-RTRI was assessed using Cohen’s Kappa. We compared recent versus long-term HIV classification across testing locations using the national RITA as a reference. Four focus group discussions (FGDs) with health staff explored perceptions of POC-RTRI implementation. Agreement between POC and laboratory RTRI was 96.5%, with a Kappa of 0.812 (95% CI: 0.704–0.920). The POC-RTRI results indicated more recent infections than laboratory-RTRI (30 vs 27), with three POC-RTRI false positives resulting in reduced sensitivity 85.0% compared to 100.0% sensitivity against RITA. FGD participants (n=28) agreed that POC RTRI is feasible and acceptable with adequate training, human resources, client counselling, and quality assurance measures. There was strong concordance between POC- and laboratory-RTRI results. The findings support the feasibility of implementing RTRI at POC by non-laboratory health workers, provided adequate training and system resources are in place.
Dataset DOI: 10.5061/dryad.k98sf7mnf
Description of the data and file structure
The REACHZ project proposed to evaluate the effectiveness of returning HIV recency testing to individuals. Secondary aims included the capacity to deliver point-of-care rapid tests for HIV recency compared to rapid tests for HIV recency completed in a central laboratory. That comparison is evaluated using the data here.
Files and variables
File: REACHZ_Dryad-20apr2026.csv
Description: The following variables were used to develop the analysis conducted in the manuscript published by PLOS One entitled "The Asanté™ HIV-1 Rapid Recency® Assay is reliable, feasible, and acceptable for use at the point-of-care in Lusaka, Zambia."
Variables
-
Variable name: marital_status
Description: What is the participant’s marital status
-
Variable name: sex
Description: Sex of the participant
-
Variable name: age_cat
Description: Age category
Label: age_cat
-
Variable name: date_mon
Description: Month of Study Enrollment
-
Variable name: asante_result
Description: Recent infection testing algorithm result
-
Variable name: educ_c4
Description: Participant educational attainment
-
Variable name: site
Description: Care facility unit label
Label: site, but the label does not exist
Code/software
Data are stored as comma-separated values (csv). Stata was used to conduct analyses.
Access information
Other publicly accessible locations of the data:
- Not applicable
Data was derived from the following sources:
- Data were collected in partnership with the Centers for Disease Control and Prevention (CDC)
Human subjects data
Data have been de-identified and anonymized to prevent disclosure of protected health information. Direct identifiers have been limited to one and indirect identifiers have been limited to three to minimize potential for re-identification. Individual informed consent was a requirement for the REACHZ study participation - details regarding informed consent may be found in the methods section of the published work associated with this data (DOI: 10.1371/journal.pone.0346868).
